TELO vs. ENVB

Last updated Apr 1, 2026

Compare and contrast key facts about Telomir Pharmaceuticals, Inc (TELO) and Enveric Biosciences Inc (ENVB).

Performance

TELO vs. ENVB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Telomir Pharmaceuticals, Inc (TELO) and Enveric Biosciences Inc (ENVB). The values are adjusted to include any dividend payments, if applicable.

TELO vs. ENVB - Yearly Performance Comparison

	2026 (YTD)	2025	2024
TELO Telomir Pharmaceuticals, Inc	-2.26%	-67.72%	-17.60%
ENVB Enveric Biosciences Inc	-46.56%	-94.37%	-53.47%

Fundamentals

EPS TELO : -$0.33 ENVB : -$36.76
Total Revenue (TTM) TELO : $0.00 ENVB : $0.00
Gross Profit (TTM) TELO : $0.00 ENVB : -$243.86K
EBITDA (TTM) TELO : -$10.48M ENVB : -$9.48M

Returns By Period

In the year-to-date period, TELO achieves a -2.26% return, which is significantly higher than ENVB's -46.56% return.

TELO

• 1D: 14.04%
• 1M: 2.36%
• YTD: -2.26%
• 6M: -6.47%
• 1Y: -59.75%
• 3Y*: —
• 5Y*: —
• 10Y*: —

ENVB

• 1D: 8.38%
• 1M: -17.45%
• YTD: -46.56%
• 6M: -74.72%
• 1Y: -88.37%
• 3Y*: -81.36%
• 5Y*: -85.29%
• 10Y*: -74.35%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

TELO vs. ENVB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TELO

TELO Risk / Return Rank: 15
TELO Sharpe Ratio Rank: 19
TELO Sortino Ratio Rank: 19
TELO Omega Ratio Rank: 20
TELO Calmar Ratio Rank: 1
TELO Martin Ratio Rank: 15

ENVB

ENVB Risk / Return Rank: 7
ENVB Sharpe Ratio Rank: 13
ENVB Sortino Ratio Rank: 6
ENVB Omega Ratio Rank: 6
ENVB Calmar Ratio Rank: 2
ENVB Martin Ratio Rank: 6

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TELO vs. ENVB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Telomir Pharmaceuticals, Inc (TELO) and Enveric Biosciences Inc (ENVB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TELO	ENVB	Difference
Sharpe ratio Return per unit of total volatility	-0.49	-0.66	+0.17
Sortino ratio Return per unit of downside risk	-0.54	-1.47	+0.93
Omega ratio Gain probability vs. loss probability	0.94	0.81	+0.13
Calmar ratio Return relative to maximum drawdown	-1.01	-0.99	-0.02
Martin ratio Return relative to average drawdown	-1.30	-1.63	+0.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TELO vs. ENVB - Sharpe Ratio Comparison

The current TELO Sharpe Ratio is -0.49, which is comparable to the ENVB Sharpe Ratio of -0.66. The chart below compares the historical Sharpe Ratios of TELO and ENVB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	TELO	ENVB	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.49	-0.66	+0.17
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.58	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.47	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.34	-0.47	+0.13

Correlation

The correlation between TELO and ENVB is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

TELO vs. ENVB - Dividend Comparison

Neither TELO nor ENVB has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

TELO vs. ENVB - Drawdown Comparison

The maximum TELO drawdown since its inception was -90.92%, smaller than the maximum ENVB drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for TELO and ENVB.

Drawdown Indicators

	TELO	ENVB	Difference
Max Drawdown Largest peak-to-trough decline	-90.92%	-100.00%	+9.08%
Max Drawdown (1Y) Largest decline over 1 year	-65.50%	-89.71%	+24.21%
Max Drawdown (5Y) Largest decline over 5 years	—	-99.99%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-100.00%	—
Current Drawdown Current decline from peak	-89.08%	-100.00%	+10.92%
Average Drawdown Average peak-to-trough decline	-69.51%	-85.81%	+16.30%
Ulcer Index Depth and duration of drawdowns from previous peaks	51.47%	54.72%	-3.25%

Volatility

TELO vs. ENVB - Volatility Comparison

Telomir Pharmaceuticals, Inc (TELO) has a higher volatility of 24.71% compared to Enveric Biosciences Inc (ENVB) at 16.58%. This indicates that TELO's price experiences larger fluctuations and is considered to be riskier than ENVB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TELO	ENVB	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.71%	16.58%	+8.13%
Volatility (6M) Calculated over the trailing 6-month period	56.13%	118.52%	-62.39%
Volatility (1Y) Calculated over the trailing 1-year period	122.60%	133.59%	-10.99%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	137.10%	148.17%	-11.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	137.10%	161.47%	-24.37%

Financials